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Objective: Flow mismatch between the supplying artery and the myocardial perfusion
region has been observed in patients with internal thoracic artery grafts. Thus coronary
flow changes of arterial (internal thoracic artery grafts) and saphenous (saphenous vein
grafts) bypass grafts were studied early and late after coronary artery bypass grafting.
Methods: Thirty patients undergoing elective bypass surgery (internal thoracic artery
and saphenous vein grafts) were studied intraoperatively and (17 patients) 3 to
10 months postoperatively. Coronary flow was measured intraoperatively with the
transit-time Doppler scanning technique. Postoperatively, flow velocity and coronary
flow reserve were determined with the Doppler flow wire technique. Quantitative an-
giographic analysis was used to determine vessel size for calculation of absolute flow.
Results: Intraoperatively, internal thoracic artery graft flow was significantly lower
than saphenous vein graft flow (31 6 8 vs 58 6 29 mL/min, P , .01). Postopera-
tively, internal thoracic artery graft flow increased significantly to 42 6 24 mL/min
at 3 months and to 56 6 30 mL/min (P , .02 vs intraoperative value) at 10 months,
respectively. However, saphenous vein graft flow remained unchanged over time
(58 6 29 to 50 6 27 mL/min at 3 months and 46 6 27 mL/min at 10 months). Cor-
onary flow reserve was abnormally low intraoperatively in the internal thoracic artery
(1.36 0.3) and saphenous vein (1.66 0.5) grafts but increased significantly to normal
values in both types of graft at follow-up.
Conclusions: Bypass flow of the internal thoracic artery graft is significantly reduced
intraoperatively when compared with that of the saphenous vein graft. However, 3 and
10 months after the operation, flow of the internal thoracic artery graft increases sig-
nificantly and is similar to saphenous vein graft flow. This finding can be explained by
an early flow mismatch of the native internal thoracic artery in the presence of a large
perfusion territory. During follow-up, there is vascular remodeling of the internal
thoracic artery, probably because of endothelium-mediated mechanisms.
C
oronary artery bypass grafting (CABG) has been associatedwith excellent clin-
ical results with regard to outcome and long-term follow-up.1 However, clini-
cal results have been shown to be different for saphenous vein grafts (SVGs)
and internal thoracic artery (ITA) grafts.2,3 The type of bypass graft is crucial for clin-
ical outcome because veins and arteries have a completely different behavior with re-
gard to early adaptation to the requirements of the myocardium and long-term patency.4
Arterial revascularization with the ITA as the bypass graft has shown excellent long-
term results,5 despite the fact that early hypoperfusion can occur and can cause ischemia
and contractile dysfunction.6,7 SVGs demonstrated favorable early results, although pa-
tency rates are typically lower in venous than in arterial grafts. Degenerative changes
and abnormal vessel wall remodeling are enhanced in vein grafts, as well as increased
platelet–vessel wall interactions, and can lead to early bypass failure.2,8-10
The purpose of this study was to assess early vascular adaptation of arterial and
venous bypass grafts and to determine vascular remodeling of these grafts during
the first year of follow-up.
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CABG 5 coronary artery bypass grafting
CFR 5 coronary flow reserve
EDHF 5 endothelium-derived hyperpolarizing factor
ITA 5 internal thoracic artery
LAD 5 left anterior descending coronary artery
LV 5 left ventricular
NO 5 nitric oxide
SVG 5 saphenous vein graft
Materials and Methods
Thirty patients undergoing elective bypass grafting were included
in the present cohort study (Figure 1). Seventeen patients had
intraoperative measurements and were catheterized early (3 months,
n 5 8) or late (10 months, n 5 9) after surgical intervention for
follow-up measurements (group A). Furthermore, 13 matched pa-
tients with additional intraoperative hyperemic flow measurements
of the ITA for calculation of coronary flow reserve (CFR) but with-
out follow-up measurements were included (group B). The study
protocol was approved by the local ethics committee, and all pa-
tients provided written informed consent. Patient characteristics are
summarized in Table 1. The mean age was 63 6 9 years, 10% were
women, and 90% were men. Body mass index was 29 6 5 kg/m2.
The mean left ventricular (LV) ejection fraction was 63% 6 9%.
Twenty-five patients had multiple-vessel disease, and 5 patients
had single-vessel disease. Thirteen patients had previous myocar-
dial infarctions. Medication after bypass surgery consisted of
aspirin in 94%, b-blockers in 82%, and inhibitors of the renin
angiotensin system in 53%. Only 6% received calcium antago-
nists postoperatively. Cardiovascular risk factors included a his-
tory of hypertension in 63%, dyslipidemia in 67%, and a family
history of coronary artery disease in 37%. Obesity and diabetes
mellitus were present in 26% and 17% of cases, respectively.
Hemodynamic and angiographic data are summarized in Table 2.
LV ejection fraction was determined by means of LV angiogra-
phy. Coronary artery diameter was determined by using quanti-
tative coronary angiography with preoperative biplane coronary
angiograms. Stenosis diameter was assessed for the ITA graft
and SVG target vessels by using the Philips Integra System.
Bypass Surgery
General anesthesia was performed with fentanyl, midazolam, and
isoflurane. Cardiopulmonary bypass with mild-to-moderate
hypothermia was used. Mean cardiopulmonary bypass time was
586 25 minutes, and aortic crossclamp time was 366 15 minutes.
Twenty-six patients received an ITA graft to the left anterior de-
scending coronary artery (LAD), and all patients received 1 or 2
SVGs to the diagonal and marginal branches or to the right coronary
artery. Overall, 76 grafts were implanted, namely 26 ITA grafts and
50 SVGs. The mean number of distal anastomosis was 2.536 1.23.
All ITA grafts were carefully harvested as a pedicled graft.11
Determination of Perfusion Territory
Theperfusion territorywasdetermined frompreoperative coronary an-
giograms. The method has been validated by Seiler and colleagues.12The Journal of ThorThe perfusion territorywas calculated from the fractional length of the
coronary segments distal to the culprit lesion in relation to the total LV
coronary length. This ratio was multiplied by LV muscle mass.
Intraoperative Flow Measurements
Doppler flow measurements of ITA grafts and SVGs were obtained
5 to 10 minutes after cessation of cardiopulmonary bypass, and no
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Figure 1. Study protocol. The total number of patients is 30. Group
A contains 17 patients. Eight patients of group A have been studied
after 3 months and 9 patients after 10 months of follow-up. Group B
contains 13 patients studied intraoperatively. ITA, Internal tho-
racic artery; SVG, saphenous vein graft.
TABLE 1. Preoperative patient characteristics
All patients (n 5 30)
Male/female sex (n) 27/3
Age (y) 63 6 9
Body mass index (kg/m2) 29 6 5
LV ejection fraction (%) 63 6 9
Perfusion territory (g)
ITA region 75 6 32
SVG region 71 6 27
Cardiovascular risk factors
History of hypertension 63%
Dyslipidemia 67%
Family history of CAD 37%
Smoking 67%
Obesity 26%
Diabetes mellitus 17%
Medication (postoperatively)
Aspirin 94%
b-Blockers 82%
ACI/ARB 53%
Calcium antagonists 6%
ITA, Internal thoracic artery; SVG, saphenous vein graft; CAD, coronary ar-
tery disease; ACI, angiotensin-converting enzyme inhibitors; ARB, angioten-
sin II receptor blockers.acic and Cardiovascular Surgery c Volume 136, Number 4 877
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Intraoperative P value 3 mo P value 10 mo
10 m vs
intraoperative
P value,
multiple test
ITA
HR (beats/min) 86 6 11 ,.05 76 6 12 NS 73 6 12 NS NS
MAP (mm Hg) 77 6 9 ,.01 109 6 12 NS 100 6 13 ,.01 ,.05
RPP (beats/min 3 mm Hg) 6554 6 985 ,.03 8133 6 1293 NS 7456 6 1384 NS NS
LVEF (%) 64 6 11* NS 66 6 10 NS 57 6 22 NS NS
LAD stenosis (%) 78 6 16* NS 78 6 18 NS 85 6 13 NS NS
ITA diameter (mm) 2 2 2.43 6 0.54 NS 2.77 6 0.70 2 2
SVG
HR (beats/min) 83 6 9 ,.05 73 6 13 NS 66 6 9 ,.01 ,.05
MAP (mm Hg) 84 6 12 ,.01 104 6 11 NS 108 6 12 ,.01 ,.05
RPP (beats/min 3 mm Hg) 6887 6 936 NS 7640 6 1771 NS 7522 6 717 NS NS
LVEF (%) 62 6 13* NS 59 6 15 NS 64 6 4 NS NS
BV stenosis (%) 85 6 15* NS 84 6 17 NS 90 6 13 NS NS
SVG diameter (mm) 2 2 2.85 6 0.37 NS 2.66 6 0.76 2 2
Values are presented as means6 1 standard deviation. ITA, Internal thoracic artery; HR, heart rate;NS, not significant;MAP, mean aortic pressure; RPP, rate–
pressure product; LVEF, left ventricular ejection fraction; LAD, left anterior descending coronary artery; SVG, saphenous vein graft;BV, bypassed target vessel.
*Preoperative measurement.vasoactive drugs were administered. Transit-time Doppler flow
results were measured with the CardioMed Flowmeter (Medi-
stim).11,13,14 The size of the flow probe was either 3, 4, or 5 mm
depending on graft diameter. Phasic and mean flow were deter-
mined at rest in 26 ITA grafts and 20 SVGs. Hyperemic maximal
flow was induced with adenosine in only 13 ITA grafts but in all
SVGs (Table 3). Adenosine was infused into the left ventricle
through a transmural needle at a concentration of 24 mg $ kg21 $
min21. Simultaneously, a standard lead of the echocardiogram
and systolic, diastolic, and mean arterial pressures were recorded.
Vascular resistance was calculated from mean arterial pressure
divided by mean bypass flow. CFR was calculated for all grafts
by dividing maximal flow during adenosine infusion by baseline
flow.15-17
Follow-up
All patients were followed clinically. Eight patients were restudied
at 3 months and 9 patients were restudied at 10 months after surgical
intervention. During restudy, baseline and hyperemic flows were de-
termined in all ITA grafts and SVGs. Overall, 13 ITA grafts and 20
SVGs were studied postoperatively (Figure 1). Five SVGs were oc-
cluded at 3 or 10 months postoperatively and therefore not included.
At follow-up, the patency rate was 100% for the ITA grafts and 80%
for the SVGs, respectively.
Flow velocity was determined by using the Doppler flow wire
(Cardiometrics Flo Wire, 0.014 inch) after having reached a stable
position. Measurements were made in every graft at rest and during
vasodilation with adenosine (adenosine bolus infusion, 18 mg for the
left coronary system and 14 mg for the right). CABG diameter was
TABLE 3. Bypass flow, coronary flow reserve and coronary resistance
Intraoperative P value 3 mo P value 10 mo
10 mo vs
intraoperative
P value,
multiple test
ITA
base (mL/min) 31 6 8 NS 42 6 24 NS 56 6 30 ,.01 ,.05
Q hyper (mL/min) 41 6 15 ,.02 91 6 58 NS 149 6 70 ,.01 ,.05
CFR 1.3 6 0.3 ,.01 2.2 6 0.3 NS 2.8 6 0.6 ,.01 ,.05
CR base (mm Hg $ mL21 $ min21) 2.5 6 0.6 NS 3.8 6 2.0 NS 2.3 6 1.7 NS NS
CR hyper (mm Hg $ mL21 $ min21) 1.9 6 0.8 NS 1.8 6 1.1 NS 0.9 6 0.6 ,.01 ,.05
SVG
Q base (mL/min) 58 6 29 NS 50 6 27 NS 46 6 27 NS NS
Q hyper (mL/min) 89 6 49 NS 125 6 82 NS 122 6 81 NS NS
CFR 1.6 6 0.5 ,.01 2.4 6 0.3 NS 2.6 6 0.5 ,.01 ,.05
CR base (mm Hg $ mL21 $ min21) 2.0 6 1.5 NS 2.6 6 1.1 NS 3.3 6 2.1 .053 NS
CR hyper (mm Hg $ mL21 $ min21) 1.4 6 1.1 NS 1.1 6 0.4 NS 1.4 6 0.9 NS NS
Values are presented as means6 1 standard deviation. ITA, Internal thoracic artery;Q, flow; base, baseline;NS, not significant; hyper, hyperemic (adenosine);
CFR, coronary flow reserve; CR, coronary resistance.878 The Journal of Thoracic and Cardiovascular Surgery c October 2008
Walpoth et al Surgery for Acquired Cardiovascular DiseaseFigure 2. Original recording of flow velocity mea-
surements of the internal thoracic artery (ITA)
graft (left) and the saphenous vein graft (SVG;
right) 3 months postoperatively. The flow velocity
curve during maximal vasodilation with adeno-
sine (top) and trend analysis (bottom) is shown.
Coronary flow reserve is 2.4 for the ITA graft and
3.0 for the SVG.A
CDmeasured at the tip of the flow wire for normalization of flow veloc-
ity to flow. Absolute flow was calculated by using the following
formula: F5A,v, where F is defined as flow, A is defined as the
cross-sectional area of the vessel, and v is defined as flow velocity.18
Average flow was calculated from 3 separate flow measurements.
Graft diameters of the ITA grafts and SVGs were measured
quantitatively at 3 and 10 months postoperatively.
Statistics
Data are expressed as means6 1 standard deviation in all tables and
as means6 1 standard error of the mean in all figures. TheWilcoxon
signed-ranks test was used to compare nonparametric paired obser-
vations, and the Mann–Whitney U test was used to compare non-
parametric unpaired observations, such as comparisons between
ITA graft and SVG data, as well as between baseline and hyperemic
flows. Because multiple measurements of graft flow were made, the
Kruskal–Wallis nonparametric test for comparison of different
groups was used to compare the postoperative flow data of the
ITA grafts and SVGs. Noncontinuous descriptive parameters were
compared by using the c2 test.
Results
A representative flow velocity tracing is shown in Figure 2 in
a patient 3 months postoperatively. Flow velocity curves dur-
ing hyperemia and trend analysis are shown for the ITA graft
and the SVG. CFR is 2.4 for the ITA graft and 3.0 for the
SVG.
Hemodynamic and Angiographic Data
The perfusion territory was slightly larger in the ITA graft
than in the SVG region (75 6 32 vs 71 6 27 g, Table 1).
Heart rate was significantly higher intraoperatively than
during follow-up (Table 2). Conversely, mean arterial pres-
sure was significantly lower intraoperatively than during fol-
low-up. As a consequence, rate–pressure product was lower
intraoperatively than during early follow-up but not during
late follow-up. LV ejection fraction was similar preopera-
tively and postoperatively. Angiographic stenosis of the
vessel bypassed by the ITA (LAD stenosis) was 78% 6
16% and by the SVG was 85% 6 15% preoperatively and
did not change significantly during follow-up. ITA graft di-
ameter tended to increase slightly from 3 to 10 months post-
operatively, whereas SVG diameter even decreased slightly.The Journal of ThoBypass Flow, CFR, and Resistance
Resting bypass flow was significantly lower in the ITA graft
than in the SVG but increased during late follow-up signifi-
cantly in the ITA graft and decreased or remained unchanged
in the SVG (Table 3 and Figures 3 and 4). Maximal bypass
flow during adenosine infusion was intraoperatively signifi-
cantly lower in the ITA graft than in the SVG (Table 3)
and increased linearly and significantly after surgical inter-
vention in the ITA group (Figures 3 and 4), whereas there
was a step up of 40% in the SVGs early after CABG, which
remained unchanged during late follow-up.
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Figure 3. Bypass flow. Baseline values compared with hyperemic
flow are shown intraoperatively and 3 months and 10 months after
surgical intervention for the internal thoracic artery (ITA) graft
(top) and the saphenous vein graft (SVG; bottom).racic and Cardiovascular Surgery c Volume 136, Number 4 879
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tients at 3 months and 5 of 7 patients at 10 months postoper-
atively, whereas SVG baseline flow values increased only in
5 of 12 patients at 3 months and 1 of 8 patients at 10 months
postoperatively (P , .05).
CFR increased continuously in both ITA grafts and SVGs
(Table 3 and Figure 5). There was a significant increase in
CFR during early follow-up in both groups, and this increase
remained significant during late follow-up.
Coronary resistances at baseline and during hyperemia
showed a similar pattern in both ITA grafts and SVGs,
although there was a trend toward lower resistances in the
vein grafts (Table 3).
There were no differences in flow measurements in
patients with and without diabetes mellitus.
Differences Between ITAGraft and SVG Bypass Flow
Generally, the ITA grafts tended to have smaller flows at rest
and during hyperemia intraoperatively. During postoperative
follow-up, ITA graft flow increased both at baseline and dur-
ing hyperemia, whereas SVG flow at baseline decreased but
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Figure 4. Baseline and hyperemic flow (internal thoracic artery
[ITA] graft vs saphenous vein graft [SVG]). Baseline flow (top)
and hyperemic flows (bottom) for the ITA graft compared with
the SVG are shown intraoperatively and 3 and 10 months postop-
eratively. Baseline and hyperemic flows are significantly reduced
for the ITA graft compared with the SVG intraoperatively (P< .01).880 The Journal of Thoracic and Cardiovascular Surgery c Octincreased during maximal vasodilation early, but not late,
after revascularization. There was an 81% increase in base-
line flow and a 263% increase in maximal flow of the ITA
graft. In contrast, there was a decrease of 21% in baseline
flow and an increase of 37% in maximal flow of the SVG.
Parallel to the flow changes, graft diameter increased or
decreased (Table 2 and Figure 6). The flow increase in the
ITA grafts was associated with a 16% increase in graft diam-
eter, whereas the diameter decreased by 7% in the SVGs. For
both grafts, there was a significant correlation between flow
and diameter (Figure 6).
Discussion
Vascular remodeling has been described for the ITA after use
as a bypass vessel for the coronary arteries.19-21 Early flow
mismatch after bypass surgery has been reported for the
ITA, mainly because of the fact that this small artery often
shows vasospasms with hypoperfusion of the grafted
artery.6,22,23 However, most patients show excellent long-
term results after revascularization with vascular adaptation
of the ITA.2
The purpose of the present study was to assess vascular
adaptation of the ITA graft and SVG early and late after
bypass surgery. The following observations were made:
1. Bypass flow of the ITA graft is significantly reduced
intraoperatively when compared with that of the
SVG.
2. Vascular adaptation of the ITA graft with an increase
in resting bypass flow is observed with a 35% increase
at 3 months and an 81% increase at 10 months. Paral-
lel to the flow increase, the ITA graft diameter tends to
increase slightly from 3 to 10 months. Bypass flow at
10 months is 22% higher in the ITA graft compared
with that in the SVG.
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CD3. Vascular adaptation of the ITA graft shows approxi-
mately a doubling of baseline flow and a quadrupling
of hyperemic flow, probably because of endothelium-
mediated mechanisms.
Pathophysiologic Mechanisms
Flow mismatch in the perioperative setting can be the result
of poor surgical technique with anastomosis failure.24,25
However, vasospasms of the arterial graft, competitive flow
through the native coronary artery, or undersized bypass ves-
sels for a given myocardial perfusion territory might be other
reasons for flow-perfusion mismatch.23,26 Vasospasms have
been associated with harvesting of the ITA graft, increased
neurohormonal stress, and cardiac surgery trauma.
In the present analysis ITA graft flow was intraoperatively
approximately 50% lower than SVG flow (Table 3). In other
words, the ITA-perfused myocardial region receives only
half of the flow received by the SVG-perfused region. This
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Figure 6. Correlation between resting graft flow and graft diame-
ter early (3 months) and late (10 months) postoperatively. The inter-
nal thoracic artery (ITA) graft diameter increased by 16%, and the
saphenous vein graft (SVG) diameter decreased by 7%. There is
a significant correlation both for the ITA graft and the SVG, with
a better Pearson's regression for the ITA graft (r 5 0.86) than for
the SVG (r 5 0.60).The Journal of Thorlow-perfusion situation might cause problems in patients
with high vascular resistance, increased catecholamine drive,
and vasospasms of the ITA bypass graft. Therefore the use of
SVG has potential benefits in acute situations with low pres-
sure and high catecholamine levels.6,7,22
Early after the operation (3 months), there is an adaptation
of the ITA graft with an increase in baseline and maximal
flow, but it is still 16% lower at baseline and 27% at maximal
flow than SVG flow. These early changes in bypass flow of
the ITA graft could be explained by flow-mediated mecha-
nisms21,27 or by decreased neurohormonal stress and recov-
ery from cardiac surgery trauma.28 The endothelium is able
to respond to flow changes and produces 3 known relaxing
factors: nitric oxide (NO), prostacyclin, and endothelium-de-
rived hyperpolarizing factor (EDHF).29-32 Several reports in
the literature have shown that the ITA graft is able to produce
more prostacyclin,33 NO, and EDHF34 than the SVG. These
findings could partially explain the superior long-term pa-
tency of ITA grafts. Additionally, the endothelium-derived
factors could be responsible for the adaptation of ITA grafts
to the altered hemodynamic situation after anastomosis to the
coronary bed. Bellien and associates35 showed that NO and
EDHF are involved in flow-mediated dilatation of conduit ar-
teries. Popp and colleagues36 demonstrated that the synthesis
of EDHF can be mechanically stimulated in coronary arteries
by means of rhythmic vessel wall distension, and this sug-
gests that EDHF might contribute to the control of coronary
blood flow. All these findings suggest that analogous mech-
anisms could occur in ITAs after bypass surgery and be re-
sponsible for the adaptation of the grafts to coronary blood
flow, resulting in a positive vascular remodeling with a possi-
ble increase in graft diameter.
Vascular adaptation is, however, not complete after 3
months because adaptation continues until 10 months after
the operation. At this time point, baseline flow of the ITA graft
is 20%, and maximal flow is 22% higher than SVG flow,
which was more or less unchanged between 3 and 10 months.
The slightly higher maximal flow of the ITA graft might be
explained in part by the larger myocardial perfusion territory.
The perfusion territory, as assessed by means of quantitative
coronary angiography (Table 1), was slightly larger for the
ITA (75 g) than the SVG (71 g) perfusion region.
Interestingly, CFR is similar in both ITA grafts and SVGs
(Figure 5), increasing in both grafts from approximately 1.5
intraoperatively to 2.7 at 10 months postoperatively (both
P , .01). After 10 months, CFR amounts to 2.8 in the ITA
graft and 2.6 in the SVG, which indicates normal flow reserve
at this time after the operation. A normal flow reserve is con-
sidered to be greater than 2.5.17 Thus intraoperatively and
early postoperatively, CFR is reduced, indicating a reduction
in myocardial perfusion during high-flow situations. Thus
adaptation of the bypass to the new hemodynamic situation
requires more than 3 but less than 10 months. The changes
in CFR are similar for the ITA graft and the SVG, althoughacic and Cardiovascular Surgery c Volume 136, Number 4 881
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opposite. This suggests that the requirements of the perfused
tissues are closely regulated through CFR and not through the
maximal coronary blood flow.37 Similar observations have
previously been made after coronary stenting, when CFR in-
creased after percutaneous transluminal coronary angioplasty
from 2.5 to 3.1 at 6 months’ follow-up.38
From a theoretic standpoint, it might be possible that cor-
onary resistance is different in LAD territories than in non-
LAD territories, and thus flow is less in ITA grafts than in
SVGs. However, previous data from Flemma and coworkers6
suggest that this is probably not the case because they showed
a 2 to 3 times higher flow in the SVG than in the ITA graft
when both were anastomosed to the LAD.
Patients with previous myocardial infarctions had slightly
lower LV ejection fractions (56% vs 63%) than those
without. Coronary flow in these regions was, however, sim-
ilar intraoperatively (33 vs 27 mL/min for ITA grafts and 52
vs 58 mL/min for SVGs), suggesting no direct effect of myo-
cardial viability on coronary flow in this setting.
Study Limitations
Intraoperative flow measurements are dependent on the mea-
suring site and the fit of the flow probe on the examined ves-
sel (coupling factor). However, optimal coupling between
the flow probe and the bypass graft was achieved by selecting
the appropriate probe size (ie, a 3- to 4-mm flow probe for the
ITA graft and a 4- to 5-mm probe for the SVG).
Intraoperative and postoperative hemodynamics are
clearly different. During the operation, heart rate is higher
and blood pressure lower, and as a consequence, the rate–
pressure product is reduced. Thus oxygen requirements of
the myocardium are reduced, and bypass flow is less than un-
der stable conditions.39
The method of blood flow measurement differs intraopera-
tively and postoperatively. This could be a source of a certain
methodological bias. There are several studies comparing
electromagnetic flow measurements with Doppler Flow wire
data.18,40 Electromagnetic flow probes have been compared
with transit-time Doppler probes, with excellent correlations
between the 2 techniques.14 Bothmethods have been validated
as reliable tools for flow and flow-velocity measurements, re-
spectively.14,18 Thus although both methods differ, the results
are comparable and are based on the same technique.
The number of patients is rather small, but this kind of
examination is demanding, and patients have to undergo
a second round of elective coronary angiography with its un-
pleasant side effects. Therefore patients are different between
the early and late postoperative examinations.
Clinical Implications
Earlypostoperativehypoperfusionofup to50%ispossiblewith
ITA grafts. This phenomenon is due to the undersized native
ITA vessel, which is connected to a high-flow perfusion bed.882 The Journal of Thoracic and Cardiovascular Surgery c OcIn contrast, the SVG permits maximal perfusion immedi-
ately after implantation and thus provides hemodynamic ad-
vantages in acute situations with low pressure and high
catecholamine drive.6,7,22 However, in the ITA graft vascular
adaptation occurs early after the operation, with a flow dou-
bling at 10 months. There is a linear increase after the oper-
ation in baseline and maximal bypass flows of the ITA,
with a possible increase in graft diameter (Figures 4 and 6),
whereas the SVG shows a decrease in baseline flow and
a step up (40%) of maximal flow in the early postoperative
phase that remains unchanged at 10 months’ follow-up.
This finding is paralleled by an unchanged or even slightly
decreased SVG diameter. In a subgroup analysis of diabetic
patients, no differences in vascular resistance or CFR were
found.
Thus vascular adaptation of the ITA graft is an important
mechanism of this type of artery, which allows flow normal-
ization over time with optimal perfusion of the bypassed
artery. However, there is a time delay in the adaptation that
lasts up to 10 months. This finding suggests a positive vascu-
lar remodeling of the artery.
From a practical standpoint, hypoperfusion of the LAD
territory by an undersized ITA graft has to be taken into con-
sideration and might improve over time. Postoperative appli-
cation of intravenous nitrates (cave low perfusion pressure)
or calcium antagonists might improve the limited ITA graft
flow situation. Some surgeons recommend the general use
of calcium antagonists for up to 3 months after ITA bypass
surgery to compensate for a potential hypoperfusion of the
ITA-grafted territory.
We thank the personnel of the operating room and the catheter-
ization laboratories for their help during the study.
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